Comments
Granules India on Wednesday informed the exchanges that its subsidiary Granules Pharmaceuticals, Inc has received EIR for its unit located at Chantilly, Virginia.
The US FDA has issued the Establishment Inspection Report for Granules Pharmaceuticals, Inc., a wholly-owned foreign subsidiary. The facility was inspected by the US FDA in December 2017 and there was one observation during the inspection.
The company has responded to the observation within the stipulated time-frame, it further said. Shares of Granules India gained 0.94 per cent at ₹118.40 on the NSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.